Unknown

Dataset Information

0

Alternative approaches to Hsp90 modulation for the treatment of cancer.


ABSTRACT: Hsp90 is responsible for the conformational maturation of newly synthesized polypeptides (client proteins) and the re-maturation of denatured proteins via the Hsp90 chaperone cycle. Inhibition of the Hsp90 N-terminus has emerged as a clinically relevant strategy for anticancer chemotherapeutics due to the involvement of clients in a variety of oncogenic pathways. Several immunophilins, co-chaperones and partner proteins are also necessary for Hsp90 chaperoning activity. Alternative strategies to inhibit Hsp90 function include disruption of the C-terminal dimerization domain and the Hsp90 heteroprotein complex. C-terminal inhibitors and Hsp90 co-chaperone disruptors prevent cancer cell proliferation similar to N-terminal inhibitors and destabilize client proteins without induction of heat shock proteins. Herein, current Hsp90 inhibitors, the chaperone cycle, and regulation of this cycle will be discussed.

SUBMITTER: Hall JA 

PROVIDER: S-EPMC4406230 | BioStudies | 2014-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC5892428 | BioStudies
2014-01-01 | S-EPMC4090037 | BioStudies
1000-01-01 | S-EPMC5921262 | BioStudies
2015-01-01 | S-EPMC4608684 | BioStudies
2005-01-01 | S-EPMC1135010 | BioStudies
2011-01-01 | S-EPMC3144320 | BioStudies
2006-01-01 | S-EPMC1383513 | BioStudies
2020-01-01 | S-EPMC6965345 | BioStudies
2019-01-01 | S-EPMC6406450 | BioStudies
2019-01-01 | S-EPMC6426937 | BioStudies